• Mashup Score: 0

    An evaluation of nearly 19,000 patients with metastatic colorectal cancer supported clinical trial data that immunotherapy significantly extended OS compared with chemotherapy for those with microsatellite instability-high disease.Additionally, researchers found a “sliver of hope” that certain individuals with microsatellite stable (MSS) disease also could benefit from immune

    Tweet Tweets with this article
    • Researchers discovered a “sliver of hope” that certain patients with microsatellite stable #colorectalcancer may benefit from #immunecheckpointinhibitors. @SchmitLab @ClevelandClinic https://t.co/YAbwagnPOR